Three-drug combination therapy for the treatment of inflammatory bowel disease

摘要

The present invention is a novel method of treating inflammatory bowel disease, such as Crohn's disease (CD) or ulcerative colitis, in a human patient, comprising administering to the patient a combination therapy comprising an anti-α4β7 antibody, a TNFα antagonist and an immunomodulatory agent. It is characterized by